Allergy & Clinical Immunology News
- Tick-Borne Illnesses Are on the Rise in Canada
- Alert Anzupgo Approved in Europe for Severe Hand Eczema
- Alert FDA Approves JAK Inhibitor for Alopecia Areata
- Alert EMA Backs Oral Drug for Primary Biliary Cholangitis
- 'Doesn't Fit Anything I Trained for': Treating Chronic Lyme
- A Woman, a Tuna Steak, and Allergy-like Symptoms
- AIDS 2024 Twice-Yearly PrEP Gives 'Huge' 100% Protection
- EULAR 2024 Taper, Dose Down, Discontinue: Striving for Less Steroid Use
- EULAR 2024 Breaking Rheumatology's Reliance on Steroids: New Strategies
- GRAPPA 2024 MHC-1-Opathies Linked to Ancient Retrovirus Infections
- Delgocitinib Effective for Hand Eczema in Phase 3 Studies
- The Case of the Drunken Teetotaler
- AIDS 2024 Remembering HIV Leaders Shot Down in Plane
- SPD 2024 Underserved Families Sound Off on Pediatric Derm Access
- Brazil Bucked the Trend in Childhood Vaccination in 2023
- SPD 2024 Munchausen Syndrome by Proxy: Be Aware of Cutaneous Signs
- SPD 2024 Colchicine Effective for Pediatric Aphthous Ulcers
- New Benzoyl Peroxide Research: Reassuring
- SPD 2024 Consider Risks for Some Topical Ingredients in Children
- Tattoo Ink Contaminated With Bacteria